Liquid Biopsy Predicts Esophageal Cancer Patient Response to Treatment
Biospace,
ROCKVILLE, Md.--( BUSINESS WIRE )--, a privately-held biotechnology company has pioneered a blood test to predict treatment…
ROCKVILLE, Md.--( BUSINESS WIRE )--, a privately-held biotechnology company has pioneered a blood test to predict treatment…
Currently, no other blood test predicts treatment response for Stage I-III esophageal cancer therapies.
The paper was published in the Journal of Translational Medicine. ROCKVILLE, Md.–(BUSINESS WIRE)–Creatv MicroTech, a privately-he…
ROCKVILLE, Md.--(Business Wire)-- Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test to…